单细胞解析揭示 CD5 或 CD7 靶向 CAR-T 细胞治疗后的免疫失调 Single-Cell Dissection Reveals Immune Dysregulation After CD5 or CD7-Directed Chimeric Antigen Receptor T-Cell Therapy. PubMed 2025/11/25 发表Adv Sci (Weinh)Q1 · IF 14.1(JCR 2025) 靶点:CD19靶点:CD22靶点:CD7技术:CAR-T技术:NK 细胞急性淋巴细胞白血病
单次高强度运动增强利妥昔单抗在体外对人慢性淋巴细胞白血病 B 细胞的疗效 A single bout of vigorous intensity exercise enhances the efficacy of rituximab against human chronic lymphocytic leukaemia B-cells ex vivo. PubMed 2024/03/17 发表Brain Behav ImmunQ1 · IF 7.5(JCR 2025) 靶点:CD19靶点:CD20靶点:CD5技术:NK 细胞慢性淋巴细胞白血病地区:欧洲
比较接受化学免疫治疗或依鲁替尼治疗的慢性淋巴细胞白血病患者血液免疫组库与临床特征 Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib PubMed 2023/12/04 发表Front OncolQ2 · IF 3.4(JCR 2025) 靶点:CD19靶点:CD5技术:NK 细胞慢性淋巴细胞白血病地区:美国